Loading...
12 Argentina Genetic Disorder Drugs Reports
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Abbvie, Gilead Sciences, Mylan, Alaxia, Vertex Pharmaceuticals
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: AstraZeneca, GlaxoSmithKline, Merck, Pfizer, Valerio Therapeutics
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Amicus Therapeutics, EpiVax, Sanofi, Avrobio, Astellas Pharma
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Bayer, Pfizer, Takeda Pharmaceuticals, Sanofi, Novo Nordisk
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Pfizer, Bayer, Novo Nordisk, CSL Limited (CSL Behring), BioMarin
Country Covered: Argentina
Study Period: 2020 - 2030
Major Players: Bayer, Novartis, Pfizer, Sanofi, Bluebird Bio
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Bluebird Bio, Novartis, ApoPharma, Bellicum Pharmaceuticals, Pfizer
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: CSL Behring, Grifols, Takeda Pharmaceuticals, Octapharma, Bio Products Laboratory
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: CSL Behring, Takeda Pharmaceuticals, Pharming Healthcare, Sanofi, BioCryst Pharmaceuticals
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Novartis, Emmaus Medical, Sanofi, Bluebird bio, Inc., Pfizer
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Pfizer, Alnylam Pharmaceuticals, Teva Pharmaceutical Industries, Neurocrine Biosciences, Ionis Pharmaceuticals
Country Covered: Argentina
Study Period: 2019 - 2030
Major Players: Sanofi, Global Blood Therapeutics, Bluebird Bio, EMI Holding, Celgene